AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 278: H623-H632, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Togane, Y.
Right arrow Articles by Katayama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Togane, Y.
Right arrow Articles by Katayama, S.
Vol. 278, Issue 2, H623-H632, February 2000

Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury

Yuko Togane1, Toshisuke Morita2, Makoto Suematsu3, Yuzuru Ishimura3, Jun-Ichi Yamazaki1, and Shigehiro Katayama2

1 First Department of Internal Medicine, School of Medicine, Toho University, Tokyo 143-8540; 2 Fourth Department of Internal Medicine, Saitama Medical School, Saitama 350-0495; and 3 Department of Biochemistry, School of Medicine, Keio University, Tokyo 160-8582, Japan

We reported that carbon monoxide (CO) generated through heme oxygenase (HO) inhibits mitogen-induced proliferation of vascular smooth muscle cells (VSMCs). We report that balloon injury induces HO-1, the stress-inducible isozyme of HO, in VSMCs and inhibits neointimal formation through the action of endogenous CO. Northern blot analysis and immunohistochemistry revealed that HO-1 is markedly induced in the media as early as 1 day after injury, whereas only a little expression was detected in the intact carotid artery. The neointimal proliferative changes were augmented or inhibited by the HO inhibitors or inducer, respectively, and effects of these interventions were not altered by suppression of endogenous nitric oxide (NO), if any. To elucidate the mechanisms by which HO controls the proliferative changes, effects of alterations in the HO reaction were examined by determining angiotensin II-elicited VSMC proliferation in vitro: the HO inducer attenuated and its inhibitor restored the proliferative response to angiotensin II (1 nM and 100 nM). Hemoglobin, a reagent trapping both NO and CO, but not met-hemoglobin, which can capture NO but not CO, augmented the proliferative response. These data suggest that endogenous CO serves as a protective factor that limits the excessive VSMC proliferation associated with vascular diseases.

heme oxygenase; balloon injury; vascular smooth muscle cell; proliferation; atherosclerosis


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
J.-H. Liu, P.-W. Lin, Y.-L. Liu, H.-H. Lin, and C.-C. Huang
Comparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patients
Postgrad. Med. J., August 1, 2007; 83(982): 547 - 551.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Hill-Kapturczak and A. Agarwal
Haem oxygenase-1--a culprit in vascular and renal damage?
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1495 - 1499.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Kronke, A. Kadl, E. Ikonomu, S. Bluml, A. Furnkranz, I. J. Sarembock, V. N. Bochkov, M. Exner, B. R. Binder, and N. Leitinger
Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome Proliferator-Activated Receptors
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1276 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Tiroch, W. Koch, N. von Beckerath, A. Kastrati, and A. Schomig
Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting
Eur. Heart J., April 2, 2007; 28(8): 968 - 973.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-m. Liu, M. A. Azam, K. J. Peyton, D. Ensenat, A. N. Keswani, H. Wang, and W. Durante
Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries
Cardiovasc Res, April 1, 2007; 74(1): 169 - 179.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. J. Wu, K. Kathir, P. K. Witting, K. Beck, K. Choy, C. Li, K. D. Croft, T. A. Mori, D. Tanous, M. R. Adams, et al.
Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging
J. Exp. Med., April 17, 2006; 203(4): 1117 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. S. Neto, A. Nakao, H. Toyokawa, M. A. Nalesnik, A. J. Romanosky, K. Kimizuka, T. Kaizu, N. Hashimoto, O. Azhipa, D. B. Stolz, et al.
Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F324 - F334.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Wu and R. Wang
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. J. Dzau, M. Gnecchi, and A. S. Pachori
Enhancing Stem Cell Therapy Through Genetic Modification
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1351 - 1353.
[Full Text] [PDF]


Home page
Circ. Res.Home page
N. Kaplan-Albuquerque, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff
Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells
Circ. Res., September 2, 2005; 97(5): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Morita
Heme Oxygenase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Gulesserian, C. Wenzel, G. Endler, R. Sunder-Plassmann, C. Marsik, C. Mannhalter, N. Iordanova, M. Gyongyosi, J. Wojta, S. Mustafa, et al.
Clinical Restenosis after Coronary Stent Implantation Is Associated with the Heme Oxygenase-1 Gene Promoter Polymorphism and the Heme Oxygenase-1 +99G/C Variant
Clin. Chem., September 1, 2005; 51(9): 1661 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Li, K. Tanaka, K. Morioka, T. Uesaka, N. Yamada, A. Takamori, M. Handa, S. Tanabe, and A. Ihaya
Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1370 - 1375.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Omura, H. Suzuki, M. Toyofuku, R. Ozono, N. Kohno, and K. Igarashi
Effects of genetic ablation of bach1 upon smooth muscle cell proliferation and atherosclerosis after cuff injury
Genes Cells, March 1, 2005; 10(3): 277 - 285.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Schillinger, M. Exner, W. Mlekusch, M. Haumer, S. Sabeti, R. Ahmadi, O. Wagner, and E. Minar
Effect of Smoking on Restenosis during the 1st Year after Lower-Limb Endovascular Interventions
Radiology, June 1, 2004; 231(3): 831 - 838.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y.-H. Chen, L.-Y. Chau, M.-W. Lin, L.-C. Chen, M.-H. Yo, J.-W. Chen, and S.-J. Lin
Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting
Eur. Heart J., January 1, 2004; 25(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor
Different Faces of the Heme-Heme Oxygenase System in Inflammation
Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. F. Ndisang, L. Wu, W. Zhao, and R. Wang
Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats
Blood, May 15, 2003; 101(10): 3893 - 3900.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Ndisang, W. Zhao, and R. Wang
Selective Regulation of Blood Pressure by Heme Oxygenase-1 in Hypertension
Hypertension, September 1, 2002; 40(3): 315 - 321.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
W. Durante
Carbon monoxide and bile pigments: surprising mediators of vascular function
Vascular Medicine, August 1, 2002; 7(3): 195 - 202.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. Morse and A. M. K. Choi
Heme Oxygenase-1 . The "Emerging Molecule" Has Arrived
Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Ishikawa, D. Sugawara, X.-p. Wang, K. Suzuki, H. Itabe, Y. Maruyama, and A. J. Lusis
Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice
Circ. Res., March 16, 2001; 88(5): 506 - 512.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Imai, T. Morita, T. Shindo, R. Nagai, Y. Yazaki, H. Kurihara, M. Suematsu, and S. Katayama
Vascular Smooth Muscle Cell-Directed Overexpression of Heme Oxygenase-1 Elevates Blood Pressure Through Attenuation of Nitric Oxide-Induced Vasodilation in Mice
Circ. Res., July 6, 2001; 89(1): 55 - 62.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online